Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-065728
Filing Date
2014-11-06
Accepted
2014-11-06 16:56:42
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v392555_10q.htm 10-Q 256890
2 EXHIBIT 31.1 v392555_ex31-1.htm EX-31.1 10526
3 EXHIBIT 31.2 v392555_ex31-2.htm EX-31.2 10406
4 EXHIBIT 32.1 v392555_ex32-1.htm EX-32.1 4925
5 EXHIBIT 32.2 v392555_ex32-2.htm EX-32.2 4693
  Complete submission text file 0001144204-14-065728.txt   2686009

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enzn-20140930.xml EX-101.INS 329848
7 XBRL TAXONOMY EXTENSION SCHEMA enzn-20140930.xsd EX-101.SCH 29230
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20140930_cal.xml EX-101.CAL 29656
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20140930_def.xml EX-101.DEF 141618
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20140930_lab.xml EX-101.LAB 194136
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20140930_pre.xml EX-101.PRE 168380
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36435 | Film No.: 141201538
SIC: 2836 Biological Products, (No Diagnostic Substances)